ALK alterations in adult renal cell carcinoma: frequency, clinicopathologic features and outcome in a large series of consecutively treated patients

This publication has 26 references indexed in Scilit:

• Fusion Tyrosine Kinase NPM-ALK Deregulates MSH2 and Suppresses DNA Mismatch Repair Function
  The American Journal of Pathology, 2011
• The lymphoma-associated NPM-ALK oncogene elicits a p16INK4a/pRb-dependent tumor-suppressive pathway
  Blood, 2011
• Pathological, Immunohistochemical and Cytogenetic Features of Papillary Renal Cell Carcinoma With Clear Cell Features
  Journal of Urology, 2011
• ALK rearrangement in sickle cell trait‐associated renal medullary carcinoma
  Genes, Chromosomes and Cancer, 2010
• Crizotinib inALK-Rearranged Inflammatory Myofibroblastic Tumor
  New England Journal of Medicine, 2010
• Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
  New England Journal of Medicine, 2010
• International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee
  British Journal of Cancer, 2009
• Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer
  Nature, 2007
• American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer
  Journal of Clinical Oncology, 2007
• Fusion of a Kinase Gene, ALK , to a Nucleolar Protein Gene, NPM , in Non-Hodgkin's Lymphoma
  Science, 1994